Bio-Rad Laboratories, Inc. (BIO) Operating margin 2016–2025
Bio-Rad Laboratories, Inc. (BIO) operating margin by fiscal year — reported operating income divided by reported revenue.
1.8%FY2025 · since FY2016: 2.7% → 1.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 1.8% | -8.7 pp |
| FY2024 | 10.5% | -2.2 pp |
| FY2023 | 12.6% | -4.6 pp |
| FY2022 | 17.2% | +0.1 pp |
| FY2021 | 17.1% | +0.6 pp |
| FY2020 | 16.6% | +6.6 pp |
| FY2019 | 9.9% | +14.4 pp |
| FY2018 | -4.5% | -10.0 pp |
| FY2017 | 5.5% | +2.8 pp |
| FY2016 | 2.7% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice